Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/17655
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVoskoboynik, Mark-
dc.contributor.authorMar, Victoria-
dc.contributor.authorMailer, Sonia-
dc.contributor.authorColebatch, Andrew-
dc.contributor.authorFennessy, Anne-
dc.contributor.authorLogan, Aleksandra-
dc.contributor.authorHewitt, Chelsee-
dc.contributor.authorCebon, Jonathan S-
dc.contributor.authorKelly, John-
dc.contributor.authorMcArthur, Grant-
dc.date2016-01-17-
dc.date.accessioned2018-05-02T23:37:07Z-
dc.date.available2018-05-02T23:37:07Z-
dc.date.issued2016-03-
dc.identifier.citationPigment cell & melanoma research 2016; 29(2): 222-8-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/17655-
dc.description.abstractBRAF mutations at codons L597 and K601 occur uncommonly in melanoma. Clinical and pathological associations of these mutations were investigated in a cohort of 1119 patients with known BRAF mutation status. A BRAF mutation was identified in 435 patients; Mutations at L597 and the K601E mutation were seen in 3.4 and 3.2% of these, respectively. K601E melanomas tended to occur in male patients, a median age of 58 yr, were generally found on the trunk (64%) and uncommonly associated with chronically sun-damaged (CSD) skin. BRAF L597 melanomas occurred in older patients (median 66 yr), but were associated with CSD skin (extremities or head and neck location - 73.3%, P = 0.001). Twenty-three percent of patients with V600E- and 43% of patients with K601E-mutant melanomas presented with nodal disease at diagnosis compared to just 14% of patients with BRAF wild-type tumors (P = 0.001 and 0.006, respectively). Overall, these mutations represent a significant minority of BRAF mutations, but have distinct clinicopathological phenotypes and clinical behaviors.-
dc.language.isoeng-
dc.subjectBRAF K601E-
dc.subjectBRAF L597-
dc.subjectBRAF mutation-
dc.subjectprimary melanoma-
dc.titleClinicopathological characteristics associated with BRAF(K601E) and BRAF(L597) mutations in melanoma.-
dc.typeJournal Article-
dc.identifier.journaltitlePigment cell & melanoma research-
dc.identifier.affiliationMelbourne University, Parkville, Victoria, Australiaen
dc.identifier.affiliationPeter MacCallum Cancer Centre, East Melbourne, Victoria, Australia-
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationVictorian Melanoma Service, Alfred Hospital, Prahran, Melbourne, Victoria, Australia-
dc.identifier.affiliationSkin and Cancer Foundation, Melbourne, Victoria, Australia-
dc.identifier.affiliationDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia-
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia-
dc.identifier.doi10.1111/pcmr.12450-
dc.identifier.orcid0000-0002-4242-1300-
dc.identifier.pubmedid26643848-
dc.type.austinJournal Article-
dc.type.austinResearch Support, Non-U.S. Gov't-
local.name.researcherCebon, Jonathan S
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

8
checked on Oct 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.